drugset
drugset / Trial / NCT04587011

A Study to Explore Pharmacokinetics/Pharmacodynamics and Safety of Tegoprazan BID Dosing in Healthy Subjects

NCT04587011 ↗

Phase 1 Unknown 40 enrolled HK inno.N Corporation
RandomizedSequentialSingle-blindTreatment

Summary

The main purpose of this study is to explore the pharmacokinetics, pharmacodynamics and safety after twice-daily dosing of tegoprazan tablets in healthy subjects.

Timeline

Start
2020-09-24
Primary completion
2021-03
Completion
2021-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tegoprazan Other / unclassified — Oral

Indications

No indication recorded.